KRISTINA SALATA: Open Payments
NPI 1811372626 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $698 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $81 |
| Eisai Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Ozempic, Leqembi, Kerendia, SHINGRIX, Veozah, ZORYVE, JARDIANCE, TZIELD.
Industry payments across TX — which companies pay providers there.
